相似文献
1
Lobenzarit disodium inhibits the constitutive NO-cGMP metabolic pathways. Possible involvement as an immunomodulatory drug.
Mediators Inflamm. 1995;4(5):364-7. doi: 10.1155/S0962935195000597.
2
Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug.
Arthritis Rheum. 1992 Feb;35(2):168-75. doi: 10.1002/art.1780350208.
3
Effects of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression, and T cell adherence toward endothelial cells.
Arthritis Rheum. 1991 Mar;34(3):296-303. doi: 10.1002/art.1780340307.
4
The effect of CCA (Lobenzarit disodium) on the suppressor T cell function and the production of autoantibodies in New Zealand black and New Zealand white F1 mice.
Immunopharmacology. 1983 Apr;5(4):293-302. doi: 10.1016/0162-3109(83)90045-0.
5
A novel antiarthritic agent, CCA (lobenzarit disodium), and the role of thymus-derived lymphocytes in the inhibition of rat adjuvant arthritis.
Immunopharmacology. 1983 Jun;6(1):15-21. doi: 10.1016/0162-3109(83)90012-7.
6
New immunomodulator lobenzarit disodium (CCA): activation of IgE class-specific suppressor T lymphocytes and regulation of IgE antibody response enhanced by sublethal X-irradiation in SJL/J mice.
Int Arch Allergy Appl Immunol. 1987;83(3):296-302. doi: 10.1159/000234311.
7
Lobenzarit disodium (CCA) inhibits the proliferation of human endothelial cells and the activity of DNA polymerase alpha.
Agents Actions. 1992 Jul;36(3-4):312-6.
8
Alleviation of depressed immunity caused by restraint-stress, by the immunomodulator, lobenzarit disodium (disodium 4-chloro-2,2'-iminodibenzoate).
Int J Immunopharmacol. 1987;9(4):433-41. doi: 10.1016/0192-0561(87)90017-8.
9
Lobenzarit disodium (CCA) inhibits in vitro immunoglobulin production via direct interaction with B lymphocytes.
Chem Pharm Bull (Tokyo). 1992 Jan;40(1):177-81. doi: 10.1248/cpb.40.177.
10
Anti-oxidative profile of lobenzarit disodium (CCA).
Biochem Pharmacol. 1990 Nov 1;40(9):2117-22. doi: 10.1016/0006-2952(90)90243-e.
本文引用的文献
1
Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge.
Biochem Biophys Res Commun. 1993 Oct 15;196(1):280-6. doi: 10.1006/bbrc.1993.2246.
2
Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
J Exp Med. 1994 Jan 1;179(1):71-80. doi: 10.1084/jem.179.1.71.
3
4
Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.
Proc Natl Acad Sci U S A. 1972 Oct;69(10):3024-7. doi: 10.1073/pnas.69.10.3024.
5
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
Biochem Biophys Res Commun. 1987 Nov 13;148(3):1482-9. doi: 10.1016/s0006-291x(87)80299-1.
6
Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice.
Diabetes. 1989 May;38(5):558-61. doi: 10.2337/diab.38.5.558.
7
Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
Proc Natl Acad Sci U S A. 1989 Jul;86(13):5159-62. doi: 10.1073/pnas.86.13.5159.
8
Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP.
Blood. 1989 Nov 1;74(6):1885-7.
9
Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.
Biochem Biophys Res Commun. 1989 Dec 15;165(2):802-9. doi: 10.1016/s0006-291x(89)80037-3.
10
Anti-oxidative profile of lobenzarit disodium (CCA).
Biochem Pharmacol. 1990 Nov 1;40(9):2117-22. doi: 10.1016/0006-2952(90)90243-e.
Zotero 插件